Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-AM1977X Phase III Study in Otolaryngological Infections
jRCT2080222863Phase 3Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of lascufloxacin in otolaryngological infection, sponsored by Kyorin Pharmaceutical. Started May 2015; status: completed.
02
Drugs
lascufloxacin
03
Conditions
otolaryngological infection
Beyond the preview
Go deeper on jRCT2080222863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222863.